Cargando…
SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
Myxedema coma is a medical emergency with a mortality rate of 30–50%. It is a commonly missed diagnosis and can lead to multiple cardiovascular complications which are reversible with levothyroxine treatment. IV levothyroxine should be initiated based on clinical suspicion without waiting for labora...
Autores principales: | Chaker, Bayan, Chaker, Mahmoud, Alim, Hussam, El-Zein, Louna S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209670/ http://dx.doi.org/10.1210/jendso/bvaa046.1900 |
Ejemplares similares
-
SAT-507 Myxedema Coma: A Fatal Diagnosis in a Patient with No Known History of Hypothyroidism
por: Chaker, Bayan, et al.
Publicado: (2020) -
SUN-587 Oral Liothyronine (LT3) May Be Better Absorbed Compared to LT4 Tablets after Biliopancreatic Diversion Surgery
por: El-Zein, Louna, et al.
Publicado: (2019) -
SAT475 Levothyroxine and Liothyronine Treated Myxedema Coma with Irreversible Cardiopulmonary Failure: A Rare Phenomenon
por: Menon, Trisha, et al.
Publicado: (2023) -
SUN-550 Pressor Refractory, Liothyronine Responsive Myxedema Cardiogenic Shock without Myxedema Coma
por: Willis, Cornelia, et al.
Publicado: (2019) -
SAT-345 Etanercept Induced Hypercalcemia
por: Chaker, Bayan, et al.
Publicado: (2020)